158 related articles for article (PubMed ID: 11395242)
1. The influence of pathologic tumor characteristics on locoregional recurrence rates following mastectomy.
Katz A; Strom EA; Buchholz TA; Theriault R; Singletary SE; McNeese MD
Int J Radiat Oncol Biol Phys; 2001 Jul; 50(3):735-42. PubMed ID: 11395242
[TBL] [Abstract][Full Text] [Related]
2. Predictors of locoregional recurrence in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy, mastectomy, and radiotherapy.
Huang EH; Tucker SL; Strom EA; McNeese MD; Kuerer HM; Hortobagyi GN; Buzdar AU; Valero V; Perkins GH; Schechter NR; Hunt KK; Sahin AA; Buchholz TA
Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):351-7. PubMed ID: 15890574
[TBL] [Abstract][Full Text] [Related]
3. Locoregional recurrence after doxorubicin-based chemotherapy and postmastectomy: Implications for breast cancer patients with early-stage disease and predictors for recurrence after postmastectomy radiation.
Woodward WA; Strom EA; Tucker SL; Katz A; McNeese MD; Perkins GH; Buzdar AU; Hortobagyi GN; Hunt KK; Sahin A; Meric F; Sneige N; Buchholz TA
Int J Radiat Oncol Biol Phys; 2003 Oct; 57(2):336-44. PubMed ID: 12957243
[TBL] [Abstract][Full Text] [Related]
4. Locoregional failure of postmastectomy patients with 1-3 positive axillary lymph nodes without adjuvant radiotherapy.
Cheng JC; Chen CM; Liu MC; Tsou MH; Yang PS; Jian JJ; Cheng SH; Tsai SY; Leu SY; Huang AT
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):980-8. PubMed ID: 11958892
[TBL] [Abstract][Full Text] [Related]
5. Pathologic tumor size and lymph node status predict for different rates of locoregional recurrence after mastectomy for breast cancer patients treated with neoadjuvant versus adjuvant chemotherapy.
Buchholz TA; Katz A; Strom EA; McNeese MD; Perkins GH; Hortobagyi GN; Thames HD; Kuerer HM; Singletary SE; Sahin AA; Hunt KK; Buzdar AU; Valero V; Sneige N; Tucker SL
Int J Radiat Oncol Biol Phys; 2002 Jul; 53(4):880-8. PubMed ID: 12095553
[TBL] [Abstract][Full Text] [Related]
6. Locoregional failure 15 years after mastectomy in women with one to three positive axillary nodes with or without irradiation the significance of tumor size.
Fodor J; Polgár C; Major T; Németh G
Strahlenther Onkol; 2003 Mar; 179(3):197-202. PubMed ID: 12627264
[TBL] [Abstract][Full Text] [Related]
7. Locoregional recurrence patterns after mastectomy and doxorubicin-based chemotherapy: implications for postoperative irradiation.
Katz A; Strom EA; Buchholz TA; Thames HD; Smith CD; Jhingran A; Hortobagyi G; Buzdar AU; Theriault R; Singletary SE; McNeese MD
J Clin Oncol; 2000 Aug; 18(15):2817-27. PubMed ID: 10920129
[TBL] [Abstract][Full Text] [Related]
8. Long-term follow-up of axillary node-positive breast cancer patients receiving adjuvant systemic therapy alone: patterns of recurrence.
Fisher BJ; Perera FE; Cooke AL; Opeitum A; Venkatesan V; Dar AR; Stitt L
Int J Radiat Oncol Biol Phys; 1997 Jun; 38(3):541-50. PubMed ID: 9231678
[TBL] [Abstract][Full Text] [Related]
9. Predictors of locoregional recurrence after neoadjuvant chemotherapy: results from combined analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27.
Mamounas EP; Anderson SJ; Dignam JJ; Bear HD; Julian TB; Geyer CE; Taghian A; Wickerham DL; Wolmark N
J Clin Oncol; 2012 Nov; 30(32):3960-6. PubMed ID: 23032615
[TBL] [Abstract][Full Text] [Related]
10. Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy.
Truong PT; Olivotto IA; Kader HA; Panades M; Speers CH; Berthelet E
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1337-47. PubMed ID: 15817335
[TBL] [Abstract][Full Text] [Related]
11. A close or positive margin after mastectomy is not an indication for chest wall irradiation except in women aged fifty or younger.
Freedman GM; Fowble BL; Hanlon AL; Myint MA; Hoffman JP; Sigurdson ER; Eisenberg BL; Goldstein LJ; Fein DA
Int J Radiat Oncol Biol Phys; 1998 Jun; 41(3):599-605. PubMed ID: 9635708
[TBL] [Abstract][Full Text] [Related]
12. T3 disease at presentation or pathologic involvement of four or more lymph nodes predict for locoregional recurrence in stage II breast cancer treated with neoadjuvant chemotherapy and mastectomy without radiotherapy.
Garg AK; Strom EA; McNeese MD; Buzdar AU; Hortobagyi GN; Kuerer HM; Perkins GH; Singletary SE; Hunt KK; Sahin A; Schechter N; Valero V; Tucker SL; Buchholz TA
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):138-45. PubMed ID: 15093909
[TBL] [Abstract][Full Text] [Related]
13. Surgical margins and the risk of local-regional recurrence after mastectomy without radiation therapy.
Childs SK; Chen YH; Duggan MM; Golshan M; Pochebit S; Wong JS; Bellon JR
Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):1133-8. PubMed ID: 22543200
[TBL] [Abstract][Full Text] [Related]
14. The prognostic significance of the percentage of positive/dissected axillary lymph nodes in breast cancer recurrence and survival in patients with one to three positive axillary lymph nodes.
Truong PT; Berthelet E; Lee J; Kader HA; Olivotto IA
Cancer; 2005 May; 103(10):2006-14. PubMed ID: 15812825
[TBL] [Abstract][Full Text] [Related]
15. Locoregional recurrence risk factors and the impact of postmastectomy radiotherapy on patients with tumors 5 cm or larger.
Nagao T; Kinoshita T; Tamura N; Hojo T; Morota M; Kagami Y
Breast Cancer; 2014 May; 21(3):292-301. PubMed ID: 22890603
[TBL] [Abstract][Full Text] [Related]
16. Quantitative molecular diagnosis of axillary drainage fluid for prediction of locoregional failure in patients with one to three positive axillary nodes after mastectomy without adjuvant radiotherapy.
Zhang Y; Ma QY; Dang CX; Moureau-Zabotto M; Chen WK
Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):505-11. PubMed ID: 16257133
[TBL] [Abstract][Full Text] [Related]
17. Breast carcinoma with 21-gene recurrence score lower than 18: rate of locoregional recurrence in a large series with clinical follow-up.
Turashvili G; Brogi E; Morrow M; Dickler M; Norton L; Hudis C; Wen HY
BMC Cancer; 2018 Jan; 18(1):42. PubMed ID: 29304773
[TBL] [Abstract][Full Text] [Related]
18. Recursive partitioning analysis of locoregional recurrence patterns following mastectomy: implications for adjuvant irradiation.
Katz A; Buchholz TA; Thames H; Smith CD; McNeese MD; Theriault R; Singletary SE; Strom EA
Int J Radiat Oncol Biol Phys; 2001 Jun; 50(2):397-403. PubMed ID: 11380226
[TBL] [Abstract][Full Text] [Related]
19. Minimal impact of postmastectomy radiation therapy on locoregional recurrence for breast cancer patients with 1 to 3 positive lymph nodes in the modern treatment era.
Miyashita M; Tada H; Suzuki A; Watanabe G; Hirakawa H; Amari M; Kakugawa Y; Kawai M; Furuta A; Sato K; Yoshida R; Ebata A; Sasano H; Jingu K; Ohuchi N; Ishida T
Surg Oncol; 2017 Jun; 26(2):163-170. PubMed ID: 28577722
[TBL] [Abstract][Full Text] [Related]
20. Locoregional recurrence in patients with one to three positive axillary nodes after mastectomy without adjuvant radiotherapy.
Cheng JC; Chen CM; Liu MC; Tsou MH; Yang PS; Cheng SH
J Formos Med Assoc; 2000 Oct; 99(10):759-65. PubMed ID: 11061070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
